Source: Marketscreener

XBiotech: XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2024

XBiotech Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 38.53 million compared to USD 24.56 million a year ago. Basic loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago. Diluted loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago. XBiotech Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 38.53 million compared to USD 24.56 million a year ago. Basic loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago. Diluted loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago.

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
John Simard's photo - Chairman & CEO of XBiotech

Chairman & CEO

John Simard

CEO Approval Rating

80/100

Read more